MENU

KALV

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

KalVista Pharmaceuticals (KALV) Ownership - Who owns KalVista Pharmaceuticals?

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Other

Address

55 Cambridge Parkway

Phone

+1 857 999-0075

Employees

270

Web

https://www.kalvista.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

1.44B

P/E Ratio

N/A

Total Cash

285.03M

Projected Growth

N/A

Total Debt

151.5M

Revenue

1.43M

Risk (Beta)

0.07

Dividend Yield

N/A

Total Cash/Share

5.35

Total Debt/Equity

N/A

Revenue/Share

0.03 USD as % of share price

View a ticker or compare two or three

VS

VS

KALV

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KALV

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile

Details

Industry

Pharmaceuticals Other

Address

55 Cambridge Parkway

Phone

+1 857 999-0075

Employees

270

Web

https://www.kalvista.com